Therapy cessation

1 clinical trial

Quick filters

Clinical trials for Therapy cessation

1 trial across Europe

See all trials →

Quick filters

1 Clinical trial

Therapy cessation

Recruiting

Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

Registered drugNo placebo

Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Elranatamab
Sponsor:Vaestra Goetalandsregionen

Contact Research Centre

See all trials →

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.